OncNGS consortium will challenge the market launching a pre-commercial procurement procedure, a competitive process enabling the buyers to compare the developments carried out by the contracted suppliers.
The oncNGS call for tender is open! Click on the button below for more information.
We are currently in Phase 0, a preparation stage. Before the opening of the Call for tender, we defined the needs by collecting feedback of the buyer’s group during the OMC (Open Market Consultation) and translate them into requirements and specifications to direct analysis and technical dialogue with the industry. The OMC is now closed. A ‘Frequently Asked Questions’ page has been created to gather and respond all the questions we received during the OMC. A matchmaking page is also available for organisations interested in finding partners to create consortia and jointly participate in the oncNGS PCP tender.
Concepts elaboration into the competitive solutions.
Minimum 4 designs will be selected.
Overall duration : 12 months – Execution : 6 months
Development of the well outlined and functioning prototypes.
Minimum 3 designs will be selected.
Overall duration : 15 months – Execution : 12 months
the functional and technical properties of the selected solutions will be evaluated in an operational environment.
Minimum of 2 pre-commercial devices will be deployed.
Overall duratiob : 18 months – Execution : 15 months
The oncNGS consortium groups several buyers in 5 EU countries to challenge the market to develop novel affordable solutions to provide the most advanced NGS tests for cancer patients. We wish to co-develop an EU innovative tender for liquid biopsy diagnostics based on complex NGS-driven DNA profiling within a pre-commercial procurement Horizon-2020 financed project.
Please find below the last updates of the oncNGS[…]
The oncNGS consortium is delighted to announce that our[…]
We are glad to announce that the oncNGS PCP[…]